Page 2123 - Hematology_ Basic Principles and Practice ( PDFDrive )

1884.e2 Part XII Hemostasis and Thrombosis

organized into separate platelet alpha granules and differentially released. 75. Othman M, Kaur H, Emsley J: Platelet-type von Willebrand disease: new
Blood 111(3):1227–1233, 2008. insights into the molecular pathophysiology of a unique platelet defect.
50. Reed GL: Platelet secretory mechanisms. Semin Thromb Hemost Semin Thromb Hemost 39(6):663–673, 2013.
30(4):441–450, 2004. 76. Norman JE, Cunningham MR, Jones ML, et al: A novel F2RL3
51. Ren Q, Ye S, Whiteheart SW: The platelet release reaction: just when you variant predicting a Tyr157Cys substitution in protease-activated recep-
thought platelet secretion was simple. Curr Opin Hematol 15(5):537–541, tor 4 is associated with reduced receptor function in platelets. Blood
2008. 124(21):4149, 2014.
52. Lian L, Wang Y, Flick M, et al: Loss of pleckstrin defines a novel pathway 77. Masliah-Planchon J, Darnige L, Bellucci S: Molecular determinants
for PKC-mediated exocytosis. Blood 113(15):3577–3584, 2009. of platelet delta storage pool deficiencies: an update. Br J Haematol
53. Zwaal RF, Comfurius P, Bevers EM: Surface exposure of phosphatidyl- 160(1):5–11, 2013.
serine in pathological cells. Cell Mol Life Sci 62(9):971–988, 2005. 78. Seward SL, Jr, Gahl WA: Hermansky-Pudlak syndrome: health care
54. Whyte CS, Swieringa F, Mastenbroek TG, et al: Plasminogen associates throughout life. Pediatrics 132(1):153–160, 2013.
with phosphatidylserine-exposing platelets and contributes to thrombus 79. Feldmann J, Callebaut I, Raposo G, et al: Munc13-4 is essential for cyto-
lysis under flow. Blood 125(16):2568–2578, 2015. lytic granules fusion and is mutated in a form of familial hemophagocytic
55. Suzuki J, Umeda M, Sims PJ, et al: Calcium-dependent phospholipid lymphohistiocytosis (FHL3). Cell 115(4):461–473, 2003.
scrambling by TMEM16F. Nature 468(7325):834–838, 2010. 80. Al Hawas R, Ren Q, Ye S, et al: Munc18b/STXBP2 is required for
56. Heemskerk JW, Mattheij NJ, Cosemans JM: Platelet-based coagulation: platelet secretion. Blood 120(12):2493–2500, 2012.
different populations, different functions. J Thromb Haemost 11(1):2–16, 81. Markello T, Chen D, Kwan JY, et al: York platelet syndrome is a CRAC
2013. channelopathy due to gain-of-function mutations in STIM1. Mol Genet
57. Schoenwaelder SM, Yuan Y, Josefsson EC, et al: Two distinct pathways Metab 114(3):474–482, 2015.
regulate platelet phosphatidylserine exposure and procoagulant function. 82. Kunzelmann K, Nilius B, Owsianik G, et al: Molecular functions of
Blood 114(3):663–666, 2009. anoctamin 6 (TMEM16F): a chloride channel, cation channel, or
58. Nieuwland R, van der Pol E, Gardiner C, et al: Platelet-derived mic- phospholipid scramblase? Pflugers Arch 466(3):407–414, 2014.
roparticles. In Michelson AD, editor: Platelets, ed 3, San Diego, 2013, 83. Nurden AT, Pillois X, Wilcox DA: Glanzmann thrombasthenia: state
Academic Press, pp 453–467. of the art and future directions. Semin Thromb Hemost 39(6):642–655,
59. Boilard E, Nigrovic PA, Larabee K, et al: Platelets amplify inflammation 2013.
in arthritis via collagen-dependent microparticle production. Science 84. Nurden AT, Pillois X, Fiore M, et al: Expanding the Mutation Spec-
327(5965):580–583, 2010. trum Affecting alphaIIbbeta3 Integrin in Glanzmann Thrombasthenia:
60. Bledzka K, Smyth SS, Plow EF: Integrin alphaIIbbeta3: from discovery Screening of the ITGA2B and ITGB3 Genes in a Large International
to efficacious therapeutic target. Circ Res 112(8):1189–1200, 2013. Cohort. Hum Mutat 36(5):548–561, 2015.
61. Bledzka K, Pesho MM, Ma Y-Q, et al: Integrin alphaIIbbeta3. In Michel- 85. Freson K, Wijgaerts A, van Geet C: Update on the causes of platelet dis-
son AD, editor: Platelets, ed 3, San Diego, 2013, Academic Press, pp orders and functional consequences. Int J Lab Hematol 36(3):313–325,
233–248. 2014.
62. Jackson SP: The growing complexity of platelet aggregation. Blood 86. Pecci A, Balduini CL: Lessons in platelet production from inherited
109(12):5087–5095, 2007. thrombocytopenias. Br J Haematol 165(2):179–192, 2014.
63. Harrison P, Lordkipanidze M: Testing platelet function. Hematol Oncol 87. Geddis AE: Inherited thrombocytopenias: an approach to diagnosis and
Clin North Am 27(3):411–441, 2013. management. Int J Lab Hematol 35(1):14–25, 2013.
64. Harrison P, Mackie I, Mumford A, et al: Guidelines for the laboratory 88. Albers CA, Paul DS, Schulze H, et al: Compound inheritance of
investigation of heritable disorders of platelet function. Br J Haematol a low-frequency regulatory SNP and a rare null mutation in exon-
155(1):30–44, 2011. junction complex subunit RBM8A causes TAR syndrome. Nat Genet
65. Cattaneo M, Cerletti C, Harrison P, et al: Recommendations for the 44(4):435–439, S1-2, 2012.
Standardization of Light Transmission Aggregometry: A Consensus of 89. Tijssen MR, Ghevaert C: Transcription factors in late megakaryopoiesis
the Working Party from the Platelet Physiology Subcommittee of SSC/ and related platelet disorders. J Thromb Haemost 11(4):593–604, 2013.
ISTH. J Thromb Haemost 11(6):1183–1189, 2013. 90. Pecci A: Pathogenesis and management of inherited thrombocytopenias:
66. de Witt SM, Swieringa F, Cavill R, et al: Identification of platelet func- rationale for the use of thrombopoietin-receptor agonists. Int J Hematol
tion defects by multi-parameter assessment of thrombus formation. Nat 98(1):34–47, 2013.
Commun 5:4257, 2014. 91. Kahr WH, Lo RW, Li L, et al: Abnormal megakaryocyte development
67. Quiroga T, Goycoolea M, Panes O, et al: High prevalence of bleeders of and platelet function in Nbeal2(-/-) mice. Blood 122(19):3349–3358,
unknown cause among patients with inherited mucocutaneous bleeding. 2013.
A prospective study of 280 patients and 299 controls. Haematologica 92. Monteferrario D, Bolar NA, Marneth AE, et al: A dominant-negative
92(3):357–365, 2007. GFI1B mutation in the gray platelet syndrome. N Engl J Med
68. Wei AH, Schoenwaelder SM, Andrews RK, et al: New insights into the 370(3):245–253, 2014.
haemostatic function of platelets. Br J Haematol 147(4):415–430, 2009. 93. Notarangelo LD, Ochs HD: Wiskott-Aldrich Syndrome: a model for
69. Nurden AT, Nurden P: Congenital platelet disorders and understanding defective actin reorganization, cell trafficking and synapse formation.
of platelet function. Br J Haematol 165(2):165–178, 2014. Curr Opin Immunol 15(5):585–591, 2003.
70. Nurden AT, Nurden P: Inherited disorders of platelet function: selected 94. Nurden AT, Pillois X, Fiore M, et al: Glanzmann thrombasthenia-like
updates. J Thromb Haemost 13(Suppl 1):S2–S9, 2015. syndromes associated with Macrothrombocytopenias and mutations in
71. Cox K, Price V, Kahr WH: Inherited platelet disorders: a clinical approach the genes encoding the alphaIIbbeta3 integrin. Semin Thromb Hemost
to diagnosis and management. Expert Rev Hematol 4(4):455–472, 2011. 37(6):698–706, 2011.
72. Rao AK: Inherited platelet function disorders: overview and disorders of 95. Kunishima S, Kobayashi R, Itoh TJ, et al: Mutation of the beta1-tubulin
granules, secretion, and signal transduction. Hematol Oncol Clin North gene associated with congenital macrothrombocytopenia affecting
Am 27(3):585–611, 2013. microtubule assembly. Blood 113(2):458–461, 2009.
73. Andrews RK, Berndt MC: Bernard-Soulier syndrome: an update. Semin 96. Manchev VT, Hilpert M, Berrou E, et al: A new form of macrothrom-
Thromb Hemost 39(6):656–662, 2013. bocytopenia induced by a germ-line mutation in the PRKACG gene.
74. Savoia A, Kunishima S, De Rocco D, et al: Spectrum of the mutations Blood 124(16):2554–2563, 2014.
in Bernard-Soulier syndrome. Hum Mutat 35(9):1033–1045, 2014.